Can I Qualify for GLP-1 with a BMI Under 30?
Yes, in many cases. The 30 BMI threshold everyone quotes is only half the story.
The Actual FDA Criteria
The FDA approved Wegovy (semaglutide for weight loss) and Zepbound (tirzepatide for weight loss) for two distinct populations:
Group 1: BMI ≥ 30 (obesity). No additional conditions required.
Group 2: BMI ≥ 27 (overweight) WITH at least one weight-related condition:
- Type 2 diabetes
- High blood pressure (hypertension)
- High cholesterol (dyslipidemia)
- Obstructive sleep apnea
- Cardiovascular disease
- Nonalcoholic fatty liver disease (NAFLD/MASH)
That second group is huge. A BMI of 27 is roughly 180 lbs at 5’8” or 165 lbs at 5’5”. Millions of Americans fall in this range AND have at least one qualifying condition.
What the Numbers Look Like
| Height | BMI 27 Weight | BMI 30 Weight |
|---|---|---|
| 5’2” | 148 lbs | 164 lbs |
| 5’5” | 162 lbs | 180 lbs |
| 5’8” | 177 lbs | 197 lbs |
| 5’10” | 188 lbs | 209 lbs |
| 6’0” | 199 lbs | 221 lbs |
| 6’2” | 211 lbs | 234 lbs |
If your weight falls in or above the “BMI 27” column AND you have a qualifying condition, you meet the FDA criteria.
The Diabetes Pathway (BMI Doesn’t Matter)
Here’s something most people miss: Ozempic and Mounjaro are approved for Type 2 diabetes with NO BMI requirement at all. If you have Type 2 diabetes, your doctor can prescribe semaglutide (Ozempic) or tirzepatide (Mounjaro) regardless of your weight. Weight loss is a “side effect” of the diabetes treatment.
This is actually how GLP-1 prescriptions started — as diabetes drugs that happened to cause weight loss.
What About BMI Under 27?
Below 27 BMI, getting a GLP-1 prescription through standard channels becomes harder. The FDA hasn’t approved any GLP-1 for this population for weight management. But there are some pathways:
Off-label prescribing. Doctors can legally prescribe FDA-approved medications for off-label uses. Some physicians will prescribe semaglutide to patients with a BMI of 25-27 if they have metabolic markers that suggest benefit. This is a clinical judgment call, not a hard rule.
Telehealth providers vary. Some online platforms strictly follow the BMI 27+ requirement. Others use broader clinical criteria. If one provider declines you, another may have different eligibility standards. Shop around.
Emerging research supports lower BMI use. Studies are showing that people with BMIs of 25-27 who have insulin resistance, prediabetes, or metabolic syndrome may benefit significantly from GLP-1 therapy. As more data emerges, guidelines may expand.
Insurance Coverage Is a Separate Battle
Even if your doctor prescribes a GLP-1, insurance coverage depends on the plan:
Most likely to cover:
- BMI ≥ 40 (morbid obesity) — highest approval rate
- BMI ≥ 35 with comorbidities — high approval rate
- BMI ≥ 30 — moderate approval rate, often requires prior auth
- Type 2 diabetes (any BMI) — high approval rate for Ozempic/Mounjaro
Harder to get covered:
- BMI 27-29 with weight-related conditions — often denied, worth appealing
- BMI < 27 — almost never covered for weight management
Medicare starting July 2026: The GLP-1 Bridge Program covers weight loss GLP-1s for BMI ≥ 35, or BMI ≥ 27 with specific conditions (heart failure, uncontrolled hypertension, CKD stage 3a+, moderate-severe sleep apnea). See our Medicare GLP-1 coverage guide for details.
How to Maximize Your Chances
-
Document everything. Keep records of all weight-related conditions, even borderline ones. Prediabetic? Get the A1C on paper. Slightly elevated cholesterol? Get the lipid panel documented.
-
Ask for metabolic testing. Insulin resistance, elevated inflammatory markers, or fatty liver on ultrasound all strengthen your case — even if your BMI is borderline.
-
Use the right diagnosis code. Your doctor should code for the qualifying condition (e.g., E11 for Type 2 diabetes, E66 for obesity) in addition to or instead of just “weight management.”
-
Try multiple providers. Eligibility interpretation varies. A telehealth platform may approve you where your primary care doctor was hesitant.
-
Appeal denials. Insurance denials aren’t final. A letter from your doctor explaining medical necessity, with supporting lab work, overturns a significant percentage of initial denials.
The Bottom Line
BMI 30 isn’t the magic number — 27 is, as long as you have a qualifying condition. And if you have Type 2 diabetes, BMI doesn’t factor in at all. The criteria are broader than most people realize, and the system has more flexibility than the headline numbers suggest.
Check our eligibility quiz to see where you fall based on your specific health profile.
This article is for informational purposes only and does not constitute medical advice. Only a licensed healthcare provider can determine if GLP-1 medication is appropriate for you.